P&S Journal: Winter 1998, Vol.18, No.1
ALUMNI ASSOCIATION ACTIVITIES
March 19, 1997
Sarah Lederman spoke on behalf of the downtown Columbia administration concerning plans under way to celebrate Columbia's 250th anniversary in 2004. Plaques marking the sites of important events and discoveries at P&S will be prepared. Her husband, Seth Lederman'83, associate professor of medicine at P&S, also was present.
Alumni association president Lewis B. Lane'74 introduced the evening's guest speaker, his classmate Stanley Chang'74, the Edward S. Harkness Professor and Chairman of Ophthalmology at P&S. Dr. Chang reported that interest in ophthalmology as an academic discipline remains very strong at the Eye Institute. Reviewing highlights of a rich tradition of accomplishments in vision research, including the discovery of the retinoblastoma gene (the first human oncogene to be identified), the first corneal transplant in the United States, and the first use of the laser in ophthalmology, he briefed the audience on current work. Today's faculty comprises 50 clinical and 12 full-time researchers. His plans for the future of the Eye Institute include renovating the physical plant, consolidating the clinical faculty, increasing research, and redirecting basic scientific research.
June 18, 1997
Outgoing alumni president Lewis Lane'74 ceded office to his successor, friend, and classmate Lester W. Blair'74. Dr. Blair presented Dr. Lane with a ceremonial gavel and promised to follow his predecessor's lead in pleading the cause of students.
Academic scholarship was also on the agenda. Sheryl A. Jawetz'99 accepted this year's J. Lawrence Pool'32 Prize awarded to the student who contributed the most outstanding original article to the student-run P&S Medical Review. Her subject was "Dextrane: A Novel Inhibitor of Pseudomonas Aeruginosa Pathogenesis in the Murine Model of Cystic Fibrosis Lung." The prize was established by J. Lawrence Pool'32,'40MSD, the distinguished neurosurgeon, professor emeritus, and retired director of the Neurological Institute.
The evening's guest speaker was Dr. Robert S. Kass, chairman of pharmacology at P&S. "We must pursue the explosion in molecular genetics," insisted Dr. Kass, a physiologist by training and a firm believer in interdisciplinary research. He hopes to build bridges for collaborative efforts between his department and major pharmaceutical firms in the metropolitan area.
Sept. 17, 1997
Council members were updated on developments in oncology at Columbia by guest speaker Karen H. Antman'74, the Wu Professor of Oncology, chief of medical oncology, and director of the Herbert Irving Comprehensive Cancer Center. While heart disease has been the major cause of death in the United States, she predicted that by the year 2005, according to NIH estimates, cancer will take the lead. Baby boomers are approaching their 50s, the age at which cancer begins to become manifest. A past president of the American Society of Clinical Oncology, Dr. Antman is on the editorial board of the New England Journal of Medicine.